2nd Quarter - Termination
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
Client
Income
$50,000
Expenses
—
Terminated
Jun 30, 2026
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 5, 2026 | $50,000 | Replaced |
| 2nd Quarter - Termination (this page) | Oct 19, 2026 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | — |
Pharmacy PHA
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.